Leading the way to a cure

ALR and CTI are partnering to develop new lupus therapies

The Alliance for Lupus Research (ALR) and Pfizer’s Centers for Therapeutic Innovation (CTI) are partnering to discover and develop new therapies for patients living with lupus.   As part of this first-of-its-kind collaboration in lupus, ALR and CTI will support novel translational research projects driven by leading academic medical centers within the CTI network.

The partnership is designed to enable joint project teams, consisting of Pfizer scientists and academic researchers, to translate novel scientific ideas into therapeutics that address unmet medical need.

The CTI and ALR collaboration represents an evolution of the R&D ecosystem that CTI is designed to achieve, in which industry works in close partnership with academia, non-profit organizations,  and other stakeholders to advance research and benefit patients. 

This collaboration memorializes Alex D. Fayne, Chief Operating Officer for CTI who unexpectedly passed away and was devoted to establish a way that non-profit foundations and industry work together to advance academic scientific innovations towards patient benefit.

The goal of CTI-ALR partnership has been established based on the shared interest to enable clinical translation of promising research projects with leading academic researchers that will advance into new medicines in the lupus field.  In collaboration with the Academic Medical Centers (AMCs), CTI and ALR will work to identify and jointly fund up to four research programs in the lupus space to be conducted under the CTI participation terms and conditions with both the respective AMC and ALR.  The grants awarded for this jointly sponsored Research Program will be a maximum of $250,000 each year for two years.

The selection process to identify programs of interest will occur at the ALR-CTI Joint Selection Committee (JSC) level.  Once a project is selected, ALR will serve as the funding administrator, whereas CTI will continue to administer all parts of the research program through joint project teams, in collaboration with the academic investigator and oversight by the institution’s JSC.

The ALR is pleased to be partnering with CTI and hopes this program represents only the first of many alliances with other organizations to bring forward clinically differentiated programs and innovative partnerships in lupus research.

Click here to view the Request for Proposal: Alex D. Fayne Memorial Lupus Program

1.5 million

people in the U.S. have Lupus.

90 million

dollars committed to lupus research by the Alliance for Lupus Research.

We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.

Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Convio
nonprofit software